Adaptive Biotechnologies Corp 10-Q filing
Filed 2025-11-05 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-267061
- Form type
- 10-Q
- CIK
- 0001478320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1478320/000119312525267061/adpt-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Adaptive Biotechnologies Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $205.3M | - | - |
| Cost Of Revenue | $53.1M | - | - |
| Operating Income | $-44.4M | - | - |
| Net Income | $-45.9M | - | - |
| Eps Basic | -0.3 | - | - |
| Eps Diluted | -0.3 | - | - |
| Cash And Equivalents | $55.0M | - | - |
| Total Assets | $490.6M | - | - |
| Total Liabilities | $286.4M | - | - |
| Shareholders Equity | $204.4M | - | - |
| Operating Cash Flow | $-48.0M | - | - |
| Capital Expenditures | $2.3M | - | - |